227 related articles for article (PubMed ID: 31263949)
1. Association of glutathione-S-transferase p1 gene promoter methylation and the incidence of prostate cancer: a systematic review and meta-analysis.
Zhou X; Jiao D; Dou M; Chen J; Li Z; Li Y; Liu J; Han X
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1939-1948. PubMed ID: 31263949
[TBL] [Abstract][Full Text] [Related]
2. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis.
Wu T; Giovannucci E; Welge J; Mallick P; Tang WY; Ho SM
Br J Cancer; 2011 Jun; 105(1):65-73. PubMed ID: 21654682
[TBL] [Abstract][Full Text] [Related]
3. Role of glutathione-S-transferase P1 hypermethylation in molecular detection of prostate cancer.
Hashad DI; Hashad MM; Talaat IM; Ibrahim MA
Genet Test Mol Biomarkers; 2011 Oct; 15(10):667-70. PubMed ID: 21631298
[TBL] [Abstract][Full Text] [Related]
4. Association of APC, GSTP1 and SOCS1 promoter methylation with the risk of hepatocellular carcinoma: a meta-analysis.
Liu M; Cui LH; Li CC; Zhang L
Eur J Cancer Prev; 2015 Nov; 24(6):470-83. PubMed ID: 25853848
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsies.
Trock BJ; Brotzman MJ; Mangold LA; Bigley JW; Epstein JI; McLeod D; Klein EA; Jones JS; Wang S; McAskill T; Mehrotra J; Raghavan B; Partin AW
BJU Int; 2012 Jul; 110(1):56-62. PubMed ID: 22077694
[TBL] [Abstract][Full Text] [Related]
6. Impact of hormonal therapy on the detection of promoter hypermethylation of the detoxifying glutathione-S-transferase P1 gene (GSTP1) in prostate cancer.
Kollermann J; Kempkensteffen C; Helpap B; Schrader M; Krause H; Muller M; Miller K; Schostak M
BMC Urol; 2006 Jun; 6():15. PubMed ID: 16803634
[TBL] [Abstract][Full Text] [Related]
7. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
Singal R; van Wert J; Bashambu M
Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
[TBL] [Abstract][Full Text] [Related]
8. Molecular Diagnostic of Prostate Cancer From Body Fluids Using Methylation-Specific PCR (MS-PCR) Method.
Minciu R; Dumache R; Gheorghe P; Daminescu L; Rogobete AF; Ionescu D
Clin Lab; 2016; 62(6):1183-6. PubMed ID: 27468582
[TBL] [Abstract][Full Text] [Related]
9. Methylation of Glutathione-S-Transferase P1 Promotor in Egyptian Females with Breast Cancer.
Moghazy TF; ElAttar HA; Eldeeb MK; Rashad RM; Farouk AM; Farag AM
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2523-2530. PubMed ID: 31450928
[TBL] [Abstract][Full Text] [Related]
10. GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer.
Maldonado L; Brait M; Loyo M; Sullenberger L; Wang K; Peskoe SB; Rosenbaum E; Howard R; Toubaji A; Albadine R; Netto GJ; Hoque MO; Platz EA; Sidransky D
J Urol; 2014 Nov; 192(5):1542-8. PubMed ID: 24769028
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis.
Dumache R; Puiu M; Motoc M; Vernic C; Dumitrascu V
Clin Lab; 2014; 60(5):847-52. PubMed ID: 24839830
[TBL] [Abstract][Full Text] [Related]
12. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
[TBL] [Abstract][Full Text] [Related]
13. Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies.
Fang C; Wei XM; Zeng XT; Wang FB; Weng H; Long X
BMC Cancer; 2015 Nov; 15():920. PubMed ID: 26585467
[TBL] [Abstract][Full Text] [Related]
14. Glutathione-S-Transferase
Ye J; Wu M; He L; Chen P; Liu H; Yang H
Int J Endocrinol; 2023; 2023():7279243. PubMed ID: 36747996
[TBL] [Abstract][Full Text] [Related]
15. Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.
Moreira-Barbosa C; Barros-Silva D; Costa-Pinheiro P; Torres-Ferreira J; Constâncio V; Freitas R; Oliveira J; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2018 Oct; 10(1):132. PubMed ID: 30373654
[TBL] [Abstract][Full Text] [Related]
16. GSTP1 methylation in cancer: a liquid biopsy biomarker?
Gurioli G; Martignano F; Salvi S; Costantini M; Gunelli R; Casadio V
Clin Chem Lab Med; 2018 Apr; 56(5):702-717. PubMed ID: 29305565
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients.
Richiardi L; Fiano V; Vizzini L; De Marco L; Delsedime L; Akre O; Tos AG; Merletti F
J Clin Oncol; 2009 Jul; 27(19):3161-8. PubMed ID: 19470943
[TBL] [Abstract][Full Text] [Related]
18. Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis.
Gonzalgo ML; Nakayama M; Lee SM; De Marzo AM; Nelson WG
Urology; 2004 Feb; 63(2):414-8. PubMed ID: 14972513
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation and Ile105val polymorphism of
Nissar S; Sameer AS; Rasool R; Chowdri NA; Rashid F
Indian J Cancer; 2019; 56(3):248-253. PubMed ID: 31389389
[TBL] [Abstract][Full Text] [Related]
20. Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebiopsy.
Zelic R; Fiano V; Zugna D; Grasso C; Delsedime L; Daniele L; Galliano D; Pettersson A; Gillio-Tos A; Merletti F; Richiardi L
Clin Cancer Res; 2016 Feb; 22(4):984-92. PubMed ID: 26475336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
